EP300 and hepatocellular carcinoma: In this study, reverse transcription-polymerase chain reaction (RT-PCR), Western blotting, immunohistochemistry (IHC) and tissue microarray were utilized to examine the distribution and frequency of p300 expression in our HCC cohort and adjacent non-malignant liver tissues.